Dr. Lopresti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1520 San Pablo St
Suite 1000
Los Angeles, CA 90033Phone+1 323-442-5100
Education & Training
University of Southern California/Los Angeles General Medical Center (USC/LA General)Fellowship, Endocrinology, Diabetes, and Metabolism, 1984 - 1986- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 1982 - 1984
Keck School of Medicine of the University of Southern CaliforniaClass of 1981
Certifications & Licensure
CA State Medical License 1982 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- 105 citationsMHC Class I Loss Is a Frequent Mechanism of Immune Escape in Papillary Thyroid Cancer That Is Reversed by Interferon and Selumetinib Treatment In VitroTrevor E. Angell, Melissa G. Lechner, Julie K. Jang, Jonathan S. LoPresti, Alan L. Epstein
Clinical Cancer Research. 2014-12-01 - 49 citationsInfluence of fasting and refeeding on 3,3',5'-triiodothyronine metabolism in man.Jonathan S. LoPresti, David S. Gray, John T. Nicoloff
The Journal of Clinical Endocrinology and Metabolism. 1991-01-01 - 10 citationsDoes Reverse Triiodothyronine Testing Have Clinical Utility? An Analysis of Practice Variation Based on Order Data from a National Reference Laboratory.Robert L. Schmidt, Jonathan S. LoPresti, Michael T. McDermott, Suzanna M. Zick, Joely A. Straseski
Thyroid. 2018-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
